Pharming (PHAR) Enterprise Value (2019 - 2025)
Pharming's Enterprise Value history spans 7 years, with the latest figure at -$145.3 million for Q4 2025.
- Quarterly results put Enterprise Value at -$145.3 million for Q4 2025, down 164.46% from a year ago — trailing twelve months through Dec 2025 was -$145.3 million (down 164.46% YoY), and the annual figure for FY2025 was -$145.3 million, down 164.46%.
- Enterprise Value for Q4 2025 was -$145.3 million at Pharming, down from -$54.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$54.9 million in Q4 2024 to a low of -$207.3 million in Q4 2022.
- The 5-year median for Enterprise Value is -$145.3 million (2025), against an average of -$132.3 million.
- The sharpest move saw Enterprise Value surged 70.22% in 2023, then plummeted 164.46% in 2025.
- Year by year, Enterprise Value stood at -$191.9 million in 2021, then decreased by 8.03% to -$207.3 million in 2022, then soared by 70.22% to -$61.7 million in 2023, then grew by 11.01% to -$54.9 million in 2024, then plummeted by 164.46% to -$145.3 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods came in at -$145.3 million, -$54.9 million, and -$61.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.